Leblond, V., Aktan, M., Coll, C. M. F., Dartigeas, C., Kisro, J., Montillo, M., Raposo, J., Merot, J.-L., Robson, S., Gresko, E., Bosch, F., Stilgenbauer, S. and Foà, R. (2018) “Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study”, Haematologica. Pavia, Italy, 103(11), pp. 1889-1898. doi: 10.3324/haematol.2017.186387.